Publication | Closed Access

Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities

Combinatorial ChemistryMedicinal ChemistryBiochemistryMedicineNatural SciencesBrafv600e Dual InhibitorsAntioxidant ActivitiesSar InvestigationAnti-cancer AgentDrug DevelopmentPharmacologyPharmaceutical ChemistryDrug Discovery